PUBLICATIONS

 

RESEARCH PUBLICATIONS

Cunningham, TJ., Jing, H., Akerblom, I., Morgan, R., Fisher, TS., Neveu, M. (2002) Identification of the Human cDNA for New Survival/Evasion Peptide (DSEP): Studies in vitro and in vivo for Overexpression by Neural Cells. Exp Neurology 177 (1): 32-9.

Chuang, E., Fisher, T., Robbins, M., Neveu, M., Thompson, C.B.  (2000) The CD28 and CTLA4 Costimulatory Receptors Associate with the Serine/Threonine Phosphatase PP2AImmunity 13:  313-22. (cited 115 times on Scopus Database)

Singleton, D. H.; Gardner, J. P.; Andrews, G. C.; Fisher, T. S.; Duerr, J. M.; Guarino, B. C.; Nunez, D.; Alegre, M.; Neveu, M.  (2000) Peptides for elucidating the signal transduction pathways of CTLA-4 and CD28.  Pept. New Millennium,  602-604.

Chuang, E., Lee, K.M., Robbins, M.D., Duerr, J.M., Alegre, M.L., Hambor, J.E., Neveu, M.J., Bluestone, J.A., and Thompson, C.B.  (1999) Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases.  J Immunology 162:  1270-7. (cited 60 times on Scopus Database)

Moyer, J.D., Barbacci, E.G., Iwata, K.K., Morin, M.J., Neveu, M.J., Pollok, V.A., Pustilnik, L.R., Reynolds, M.M., Sloan, D., Theleman, A., and Miller P.  (1997) Induction of Apoptosis and Cell Cycle Arrest by CP-358,774 (Drug Name – Tarceva), an Inhibitor of Epidermal Growth Factor Receptor Kinase. Cancer Research 57:4838-48.  (cited 516 times on Scopus Database)

Flores, L., M., Hoegen, M., Klein, R., Lopez, O., Mazariegos, F., Neveu, M., Palma, D., Pardon, M., and Wilson de Quinones, D.  (1995) Contra la Morbilidad Infantil: Filtros Artesanales y Educacion, Universidad Rafael Landivar, Revista de Estudios Sociales.  53:  1-98. (Clinical Study for a Low Cost Water Filter for Developing Countries)

Neveu, M.J., Hully, J.R., Babcock, K., Hertzberg, E., Nicholson, B., Paul, D.L., Vaughan, J., and Pitot, H.C.  (1995) Proliferation-Associated Differences in the Spatial and Temporal Expression of Gap Junction Genes in Rat Liver.  Hepatology 22:  202-12.

Zou, Z., Anisowicz, A., Hendrix, M.J., Thor, A., Neveu, M.J., Sheng, S., Rafidi, K., Seftor, E., and Sager, R.  (1994) Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells.  Science 263:  526-9. (cited 567 times on Scopus Database)

Neveu, M.J., Hully, J.R., Hertzberg, E., Nicholson, B., Paul, D.C., and Pitot, H.C.  (1994) Multiple Mechanisms Responsible for Altered Expression of Connexin Genes During Oncogenesis in Rat Liver.  J Cell Science 107:  83-95.  (cited 71 times on Scopus Database)

Neveu, M.J., Hully, J.R., Babcock, K.L., Hertzberg, E.L., Paul, D.C., and Pitot, H.C.  (1994) Colocalized Alterations in Connexin 32 and Cytochrome P450 IIb1/2 by Phenobarbital and Related Liver Tumor Promoters.  Cancer Research  54:  3145-52.

Neveu, M.J., Hully, J.R., Sattler, C.A., Sattler, G.L., Hertzberg, E., Paul, E.C., and Pitot, H.C.  (1994) Differences in the Expression of Connexin Genes in Rat Hepatomas in Vitro and in VivoMolecular Carcinogenesis 11:  145-54.

Hully, J.R., Su, Y., Lohse, J.K., Griep, A.E., Sattler, C.A., Haas, M.J., Dragan, Y., Peterson, J., Neveu, M., and Pitot, H.C.  (1994) Transgenic Hepatocarcinogenesis in the Rat.  American J Pathology 145:  386-97.

Tomasetto, C., Neveu, M.J., Daley, J., Horan, P.K., and Sager, R.  (1993) Specificity of Gap Junction Communication Among Human Mammary Cells and Connexin Transfectants in Culture.  J Cell Biology 122:  157-67.  (cited 91 times on Scopus Database)

Sager, R., Anisowicz, A., Neveu, M.J., Liang, P., and Sotiropoulou, G.  (1993) Identification by Differential Display of Alpha 6 Integrin as a Candidate Tumor Suppressor Gene.   FASEB J 7:  964-70.  (cited 115 times on Scopus Database)

Pitot, H.C., Neveu, M.J., J.R., Sargent, L., Paul, D., and Nicholson, B. (1991) Gene Activation and Deactivation During Multistage Hepatocarcinogenesis.   Chemical Carcinogenesis 2: 49-64.

Pitot, H.C., Dragan, Y.P., Neveu, M.J., Rizvi, T.A., Hully, J.R. and Campbell, H.A.  (1991) Chemicals, Cell Proliferation, Risk Estimation, and Multistage Carcinogenesis.  Progress in Clinical and Biological Research 369: 517-532.

Neveu, M.J., Hully, J.R., Paul, D.L., and Pitot, H.C. (1990) Reversible Alteration in the Expression of the Connexin 32 During Tumor Promotion in Rat Liver and its Role During Cell Proliferation.  Cancer Communications, 2: 21-31.

Beer, D.G., and Neveu, M.J.  (1990) Proto-oncogene and Gap-Junction Protein Expression in Rodent Liver Neoplasms.  Progress in Clinical and Biological Research. 331:293-309

Rigby, H. L.; Neveu, M.; Pauley, D.; Ranu, B. C.; Hudlicky, T. (1989) 3-Hydroxy-1-cyclohexene-1-carboxaldehyde. Org. Synth. 67: 205-9.

Beer, D.G., Neveu, M.J., Paul, D.L., Rapp, U.R., and Pitot, H.C.  (1988) Expression of the c-raf  Proto- oncogene, γ-Glutamyltranspeptidase, and Gap Junction Protein in Rat Liver Neoplasms. Cancer Research, 48: 1610-1617.

Patents and Novel Gene Sequences

Hanson, D.C., Neveu, M.J., Elliott-Mueller, E., Hanke, J.H., Gilman, S.C., Davis, C.G., and Corvalan, J.R.  (2004, 2010, 2012) Human Monoclonal Antibodies to CTLA-4. US 6,682,736, US 7,807,797, US 7,824,679 and 8,143,379,  146 pp.  (Drug Name – Tremelimumab)

Hanson, D.C., Neveu, M.J., Elliott-Mueller, E., Hanke, J.H., Gilman, S.C., Davis, C.G., and Corvalan, J.R.  (2008) Nucleic acids encoding human monoclonal antibodies to CTLA-4. US 7,411,057, 145 pp. (Drug Name – Tremelimumab)

Hanson, D.C., Neveu, M.J., Elliott-Mueller, E., Hanke, J.H., Gilman, S.C., Davis, C.G., and Corvalan, J.R.  (2006) Methods and host cells for producing human monoclonal antibodies to CTLA-4. US 7,132,281, 153 pp. (Drug Name – Tremelimumab)

Hanson, D.C., Neveu, M.J., Elliott-Mueller, E., Hanke, J.H., Gilman, S.C., Davis, C.G., and Corvalan, J.R.  (2006) Human Monoclonal Antibodies to CTLA-4. World Patent WO 143,797. 208 pp. (Drug Name – Tremelimumab)

Hanson, D.C., Neveu, M.J., Elliott-Mueller, E., Hanke, J.H., Gilman, S.C., Davis, C.G., and Corvalan, J.R.  (2006) Methods for expressing and recovering human monoclonal antibodies to CTLA-4. US 7,109,003, 150 pp. (Drug Name – Tremelimumab)

Cunningham, TJ., Jing, H., Akerblom, I., Morgan, R., Fisher, TS., Neveu, M. (2001) Homo sapiens survival/evasion peptide gene, complete cds.  Accession AY44239
.
Zou, Z., Anisowicz, A., Hendrix, M.J., Thor, A., Neveu, M.J., Sheng, S., Rafidi, K., Seftor, E., and Sager, R.  (1994)  Human Maspin mRNA, complete cds.  Accession HSU04313.

Book Chapters and Review Articles

Neveu, M.J. (2006) Vitamin C and Dihydroquercetin – Creating a More Potent Vitamin C.  Life Extension Magazine.  December.

Neveu, M.J. (2006) Brain Food: Safely Manage Depression with Omega Fatty Acids.  Life Extension Magazine, September.

Neveu, M.J. (2006)  Omega-3s Aid Recovery from Mining Disaster.  Life Extenstion Magazine. August.

Neveu, M.J. (2006) Integrative Therapy of Ovarian Cancer.  Disease Prevention and Treatment, Fifth Edition. Published by Life Extension Foundation.

Neveu, M. (2004) America’s Medical and Healthcare Disaster.  Integrative Health and Self Healing.  6:  23-4.

Neveu, M.J., Blanco, R. (2003) Emerging Opportunity: Cancer Electromagnetic Frequency Therapy. Explore 12 (4): 1-9.

Neveu, M.J., Bertram, J.  (2000) Gap Junctions During Oncogenic Transformation.  Advances in Molecular Cell Biology 30: 221-62.

Neveu, M.J.  (1996) Modulation of Gap Junctions in Noncancer Endpoints.  The Toxicology Forum, 519-24.

Graham, J.D., Baird, S., Cohen, J., Evans, J., Gray, G., Neveu, M.J., Smith, A., Spedden, S., Taylor, A., Thompson, K., Wilson, R., and Yim, M-S (1992) Recommendations for Improving Cancer Risk Assessment.  National Academy of Sciences and US Environmental Protection Agencies. 1-12.

Kohler, J. (1992) Silenced Cells.  Interview with Mark Neveu, University of Wisconsin-Madison, Touchstone 24:  6-10.
 
Pitot, H.C., Neveu, M.J., Hully, J.R., Rizvi, T.A., and Campbell, H.  (1990) Multistage Hepatocarcinogenesis in the Rat as a Basis for Models of Risk Assessment of Carcinogenesis, In: S.H. Moolgavkar (Ed.), Scientific Issues in Quantitative Cancer Risk Assessment.  Birkhauser, Boston, 69-95.